Literature DB >> 10753487

Health-related quality of life in Parkinson's disease after pallidotomy and deep brain stimulation.

K Straits-Tröster1, J A Fields, S B Wilkinson, R Pahwa, K E Lyons, W C Koller, A I Tröster.   

Abstract

This study explored the multidimensional outcome of three neurosurgical interventions for Parkinson's disease (PD): pallidotomy (N = 23), pallidal deep brain stimulation (DBS) (N = 9), and thalamic DBS (N = 7). All patients completed the Sickness Impact Profile (SIP) and the Beck Depression Inventory. Pallidotomy patients also completed the Profile of Mood States, the Beck Anxiety Inventory, and a disease-specific quality of life (QOL) measure, the Parkinson's Disease Questionnaire (PDQ-39). Three months after surgery, all neurosurgical groups showed significant improvements in mood and function, including physical, psychosocial, and overall functioning. Pallidal DBS and pallidotomy patients who completed additional QOL measures reported decreased anxiety and tension, increased vigor, improved mobility and ability to perform activities of daily living, and decreased perceived stigma. Psychosocial dysfunction scores from the SIP were related to depressed mood both at baseline (r = .42) and at followup (r = .45), but the physical dysfunction subscale was not related to mood at either time point, suggesting that disruption of social relationships due to PD may have more impact on affective distress than physical symptoms alone. Results suggest that neurosurgical interventions for PD improve disabling PD motor symptoms and also improve several domains of quality of life. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10753487     DOI: 10.1006/brcg.1999.1112

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  17 in total

Review 1.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremor.

Authors:  J A Fields; A I Tröster; S P Woods; C I Higginson; S B Wilkinson; K E Lyons; W C Koller; R Pahwa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-03       Impact factor: 10.154

3.  Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation.

Authors:  M C Rodriguez-Oroz; I Zamarbide; J Guridi; M R Palmero; J A Obeso
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

4.  Depression and intelligence in patients with Parkinson's disease and deep-brain stimulation.

Authors:  Courtney R Schadt; Katie L Cox; Michael G Tramontana; Daniel W Byrne; Thomas L Davis; John Y Fang; Peter E Konrad; Bhavna Padaliya; Robert W Mutter; Chandler E Gill; Caralee R Richardson; P David Charles
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

5.  Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS).

Authors:  Pablo Martinez-Martin; Maria Jose Catalan; Julian Benito-Leon; Angel Ortega Moreno; Ivana Zamarbide; Esther Cubo; Nadeje van Blercon; Victor Campos Arillo; Margarita Pondal; Gurutz Linazasoro; Fernando Alonso; Pedro García Ruiz; Belen Frades
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

6.  Putting Wilson and Cleary to the test: analysis of a HRQOL conceptual model using structural equation modeling.

Authors:  Karen H Sousa; Oi-Man Kwok
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

Review 7.  A review of the health-related quality of life and economic impact of Parkinson's disease.

Authors:  Clare H Dowding; Claire L Shenton; Sam S Salek
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 8.  The effect of deep brain stimulation on quality of life in movement disorders.

Authors:  A Diamond; J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

Review 9.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 10.  Neuropsychiatric symptoms in Parkinson's disease.

Authors:  Dag Aarsland; Laura Marsh; Anette Schrag
Journal:  Mov Disord       Date:  2009-11-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.